Jump to content

Europe wants to make its own drugs, but it needs American blood plasma


BRUSSELS (Reuters) - Europe wants to be master of its own destiny in producing essential drugs and finding COVID-19 treatments, but it’s got a problem. It relies on the United States for a critical ingredient: blood plasma.



The coronavirus crisis should push authorities to overhaul Europe’s blood donation system, according to some industry players. The United States’ steadier plasma supplies are partly due to its system of paying people to donate blood used to develop medicines. In most European countries, donations are unpaid because of safety and ethical reasons.


By using the site you agree to our Privacy, Cookies, and Terms of Service Policies.